Follow the SPECTRANETICS CORP stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 28 January 2016 (Levée d'options). Among the most active insiders: RUGGIO JOSEPH M. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
SPECTRANETICS CORP is a company focused on developing medical technologies for the treatment of cardiovascular diseases. It is listed on the NASDAQ under the symbol SPECT.